Mentioned On
Episode Mentions
Pharma and BioTech Daily · Apr 23, 2026
Amneal's $1.1B Biosimilars Move & Merck's HIV Pill | Pharma and Biotech Daily
“Acquired by Amneal Pharmaceuticals for $1.1B to expand biosimilars capabilities”
Biosimilars Market ExpansionAI Integration in Drug DiscoveryCAR-T Therapies for Autoimmune Diseases
View Analysis